BASF has obtained approval to market its Symbiocell natural plant-based cosmetic active ingredient in China.
The active is based on an extract of Cestrum latifolium leaves for which BASF recently obtained new cosmetic ingredient notification in China.
Symbiocell (INCI: Water (and) Butylene Glycol (and) Cestrum Latifolium Leaf Extract (and) Xanthan Gum (and) Propanediol (and) Caprylyl Glycol), focuses on soothing sensitive skin and excessive cutaneous reactions.
The active is proven through in vitro tests to support healthy levels of the basal expression of CD86 in skin dendritic cells.
It effectively soothes sensitive skin and potentially excessive cutaneous reactions.
Cestrum latifolium, is well known in tropical regions for its healing properties and has known applications for a variety of skin issues.
Inspired by these properties, BASF has clinically tested a face care formulation with 2% Symbiocell and demonstrated that it reduces the level of reactivity and discomfort in sensitive skin.
The ingredient was developed in response to a growing consumer trend for cosmetic products that address common sensitive skin concerns, with Asia-Pacific being the key region in focus.
A double-blind clinical study was conducted on 31 women to compare the efficacy of a 2% concentration of Symbiocell in a face care formulation to that of a commercially available soothing, anti-redness skin care product over a three-week application period.
The results showed that cutaneous discomfort that was previously observed during a stinging test conducted on the side of the face treated with Symbiocell at 2% significantly diminished by 62%, while the average decrease for the side of the face treated with the benchmark product was 58%.
